Altered furosemide pharmacokinetics in chronic alcoholic liver disease with ascites contributes to diuretic resistance
- 1 February 1987
- journal article
- research article
- Published by Elsevier in Gastroenterology
- Vol. 92 (2) , 294-298
- https://doi.org/10.1016/0016-5085(87)90120-x
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Furosemide disposition in cirrhosisClinical Pharmacology & Therapeutics, 1982
- Pharmacokinetics of furosemide in patients with hepatic cirrhosisEuropean Journal of Clinical Pharmacology, 1982
- Resistance to DiureticsDrugs, 1981
- The Use of HPLC to Elucidate the Metabolism and Urinary Excretion of Furosemide and its Metabolic ProductsActa Pharmacologica et Toxicologica, 1981
- Dual Effects of Antidiuretic Hormone on Urinary Prostaglandin E2Excretion in Man*Journal of Clinical Endocrinology & Metabolism, 1981
- Influence of hepatic cirrhosis and end-stage renal disease on pharmacokinetics and pharmacodynamics of furosemideEuropean Journal of Clinical Pharmacology, 1981
- Frusemide Pharmacokinetics in Patients with Liver DiseaseClinical Pharmacokinetics, 1980
- Pharmacodynamic analysis of the furosemide-probenecid interaction in manKidney International, 1979
- Distribution, elimination and natriuretic effect of furosemide in patients with severe arterial hypertensionEuropean Journal of Clinical Pharmacology, 1978
- Effects of probenecid on furosemide kinetics and natriuresis in manClinical Pharmacology & Therapeutics, 1977